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Abstract
Purpose of Review Chronic rhinosinusitis and nasal polyps (CRSwNP) is a common condition that significantly affects patients’
life. This work aims to provide an up-to-date overview of CRSwNP in older adults, focusing on its aging-related clinical
presentations, pathophysiology, and comorbidity associations including asthma.
Recent Findings Recent large population-based studies using nasal endoscopy have shown that CRSwNP is a mostly late-onset
disease. Age-related changes in physiologic functions, including nasal epithelial barrier dysfunction, may underlie the incidence
and different clinical presentations of CRSwNP in older adults. However, there is still a paucity of evidence on the effect of aging
on phenotypes and endotypes of CRSwNP. Meanwhile, late-onset asthma is a major comorbid condition in patients with
CRSwNP; they frequently present with type 2 inflammatory signatures that are refractory to conventional treatments when they
are comorbid. However, as they are more commonly non-atopic, causative factors other than classical atopic sensitization, such as
Staphylococcus aureus specific IgE sensitization, are suggested to drive the type 2 inflammation. There are additional comor-
bidity associations in older patients with CRSwNP, including those with chronic otitis media and head and neck malignancy.
Summary Age is a major determinant for the incidence and clinical presentations of CRSwNP. Given the heterogeneity in
phenotypes and endotypes, longitudinal investigations are warranted to elucidate the effects of aging on CRSwNP.
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Introduction
Chronic rhinosinusitis (CRS) is one of the main chronic
conditions in adults, affecting about 10% of the general
population [1]. It is defined as chronic inflammation of the
nose and paranasal sinuses, characterized by the presence
of two or more of the following symptoms for more than
12 weeks: nasal discharge, nasal congestion or obstruction,
facial pain or pressure, and reduction or loss of smell [2].
It significantly affects patients’ quality of life, impairing
their work productivity and social life [3]. A previous
study using the 36-item Short-Form Health Survey report-
ed that the effect of CRS on bodily pain and social func-
tioning were comparable with or greater than that of other
chronic diseases such as congestive heart failure, angina
pectoris, chronic obstructive pulmonary diseases, and
chronic back pain [4].
CRS is classified into two major subgroups based on
endoscopy or computed tomography (CT) findings: CRS
without nasal polyps (CRSsNP) and CRS with nasal
polyps (CRSwNP) [2]. Nasal polyps are inflammatory
outgrowths of sinonasal tissues. They are usually benign
but may cause severe nasal obstruction and reduction or
loss of smell [5], and are frequently comorbid with se-
vere asthma [1].
Of note, CRSwNP is a late-onset disease. A review of
medical records of 4986 patients with asthma and rhinitis vis-
iting an allergy clinic in the USA showed that the frequency of
nasal polyps was significantly higher in patients older than
This article is part of the Topical Collection on Otitis
* Woo-Jung Song
swj0126@amc.seoul.kr
1 Department of Allergy and Clinical Immunology, Asan Medical
Center, University of Ulsan College of Medicine, 88, Olympic-ro
43-gil, Songpa-gu, Seoul 05505, South Korea
2 Department of Internal Medicine, Veterans Health Service Medical
Center, Seoul, South Korea
3 Upper Airways Research Laboratory, Ghent University Hospital,
Ghent, Belgium
Current Allergy and Asthma Reports (2019) 19: 46
https://doi.org/10.1007/s11882-019-0880-4
40 years [6]. The Korean National Health and Nutrition
Examination Survey (KNHANES) 2010–2012—a nation-
wide general population survey wherein nasal endoscopy
was routinely performed for all randomly recruited adult
participants—found that the prevalence of nasal polyps
increased with age in adults, being the highest in older
adults (≥ 60 years of age) (Fig. 1a; unpublished).
CRSwNP is also significantly associated with late-onset
asthma [7•]. Given the trends of global population aging
[8], its disease burden is expected to increase further in
the near future. The present review aims to provide an up-
to-date overview of CRSwNP in older adults, focusing on
its aging-related clinical presentations and comorbidity as-
sociations including asthma.
Age-Related Epidemiology of CRSwNP
Smoking is a major risk factor for the prevalence of CRS
overall. In a questionnaire-based study conducted by the
Global Allergy and Asthma European Network (GA2LEN),
the prevalence of CRS according to the European Position
Paper on Rhinosinusitis and Nasal Polyps (EP3OS) criteria
was found to be 10.9% (range 6.9–27.1%) in European
general adult populations [9]. CRS was significantly more
prevalent in smokers than in non-smokers, but its preva-
lence was inversely associated with age (vs. 15–24 years as
the reference group; for 65–74 years, odds ratio [OR] 0.64;
95% confidence interval [95% CI] 0.56–0.73) [9].
However, Chinese study performed using the same
EP3OS criteria found that older age (≥ 60 years) was not
significantly associated with CRS prevalence (vs. 0–
14 years as the reference group; OR 1.27; 95% CI 0.89–
1.82) [10]. In a Korean population survey, the prevalence
of overall CRS did not show a correlation with age (Fig.
1a) [7•]. These discrepancies in age relationships may be
attributed to the different relationships of CRSsNP and
CRSwNP with age.
Aging is however a major determinant of CRSwNP. The
study by Johansson et al. was the first to report the preva-
lence of nasal polyps in general adult populations with
objective confirmation of diagnosis using nasal endoscopy
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Fig. 1 a Age-related prevalence of chronic rhinosinusitis (CRS) with or
without nasal polyps in a nationwide Korean population study. b
Proportion of nasal symptoms with or without polyps among patients
with CRS. Results from the 2010–2012 Korean National Health and
Nutrition Examination Survey database analyses
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[11]. In a random sample of 1900 adults in Skövde,
Sweden, in 2000, the prevalence of nasal polyps was esti-
mated to be 2.7% (95% CI 1.9–3.5%). The authors de-
scribed the predicted probability of nasal polyps using a
logistic regression model and demonstrated that this nasal
condition is more prevalent in older adults, particularly
among males and those with asthma [11]. These relation-
ships with male sex and aging were also found in the
KNHANES 2008–2012 analysis [12•]. The prevalence of
CRSwNP was 2.6%, and it was significantly higher among
older males and those with asthma. Multivariate logistic
regression analyses showed that the male sex association
was independent of smoking history [12•]. Similar demo-
graphic patterns were reported in an electronic health re-
cord data analysis of 446,480 Geisinger Clinic primary
care patients in the USA [13] and in the GA2LEN cohort
of CRS patients in Europe [14]. However, the reasons un-
derlying the aging-related incidence of CRSwNP are un-
known. Smoking is an unlikely explanation for this rela-
tionship, as it was not independently associated with
CRSwNP [12•]. Similarly, a history of allergic rhinitis,
which is a usually childhood-onset disease, also shows no
significant associations with CRSwNP [7•]. Indeed, there
are different inflammatory endotypes of CRSwNP [15],
and thus, the biological pathways underlying nasal polyp
development in normal nasal mucosa are likely complex.
Pathophysiology of CRSwNP in Older Adults
CRSwNP is a heterogeneous entity, probably resulting
from complex interplays among environment, host, and
microbial factors [16, 17]. The pathophysiology is likely
to be more complex in older adults, as it would include
age-related changes in biologic functions. Physiologically,
several aging-related anatomical and functional changes—
such as decreased ciliary beat frequency, nasal mucosal
atrophy, decreased nasal vasculature, and decreased nasal
mucous secretion—may occur in the nasal mucosa [18].
Decreased ciliary beat frequency and clearance as well as
thinning and dryness of the mucosa may lead to the stasis
of thick mucus, followed by poor removal of external
irritants [18].
Hereditary factors may underlie the incidence of nasal
polyps, as the familial aggregation of CRSwNP has been
reported [19–23]. In a population database study involv-
ing 1638 patients with CRSwNP diagnosed between 1996
and 2011 in Utah, the USA, first-degree relatives of
CRSwNP patients had a 4.1-fold higher risk of having
nasal polyps than did controls [23]. In a study of 418
CRSwNP patients in China, 17.4% of participants report-
ed a family history of nasal polyps and had an earlier
disease onset than patients without a family history
(27.7 ± 12.7 vs. 32.7 ± 14.6; p < 0.05) [22]. However, it
is unknown whether hereditary factors contribute to the
development of nasal polyps in older adults and which
specific genetic factors are involved in.
Innate and adaptive immune responses may be im-
paired in older adults, which also likely increase suscep-
tibility to infection and bacterial colonization. Cho et al.
reported a significant age-related decline in the levels of
S100A8/9, members of the epidermal differentiation com-
plex, in nasal lavage samples from both CRS patients and
normal controls, suggesting that nasal epithelial barrier
dysfunction is likely an aging-related biological change
[24, 25•]. In a study of middle meatus swabs from 28
healthy participants without rhinosinusitis, advanced age
was found to be associated with the microbiome compo-
sition at the phylum level. In particular, older participants
had lower levels of Actinobacteria but concomitantly
greater abundance of Fusobacteria and Staphylococcus
aureus than younger participants [26]. S. aureus common-
ly colonizes the nasal mucosa of CRSwNP patients (up to
73.2%, as measured by nasal swab cultures) [27], and
colonization is positively associated with local levels of
immunoglobulin E (IgE) and eosinophils in nasal polyp
tissues [28].
Age-Related Immunological Phenotypes
of CRSwNP
The immunological phenotypes of CRSwNP vary geo-
graphically [29]. CRSwNP is commonly characterized
by high Th2 cytokine levels and eosinophilic inflamma-
tion in European patients, whereas non-eosinophilic
CRSwNP is more prevalent in Asian patients [30, 31,
32•, 33•]. Longitudinal comparison studies have reported
that eosinophilic CRSwNP is becoming more frequent in
Asian patients [34–36], suggesting important roles of en-
vironmental or acquired factors in developing immuno-
logical phenotypes. However, it is still unclear whether
age influences immunological phenotypes. As the studies
on CRSwNP in relation to aging are very limited, studies
on CRS (including CRSwNP) have also been discussed
herein.
A retrospective review of 252 patients with CRS visit-
ing a specialist clinic in the USA showed no significant
correlation between age and eosinophil count in nasal
polyp tissues; however, a significant inverse correlation
between age and eosinophil cationic protein levels in na-
sal lavage fluid was observed among patients with
CRSwNP (r = − 0.57, p < 0.001) [24]. Also, the proportion
of eosinophilic histologic type did not differ between
older and younger patients with CRSwNP in two different
patient samples [34, 37]. Meanwhile, in a study of Korean
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patients with non-eosinophilic CRSwNP, age showed in-
verse correlations with neutrophilic infiltration and levels
of neutrophil-associated cytokines such as IL-17A and IL-
23 in nasal polyp tissues. Further, the age-related de-
creases in levels of neutrophilic markers showed correla-
tions with better post-operative endoscopic scores [38•].
However, in a study of 147 CRS patients undergoing en-
doscopic sinus surgery (ESS) in the USA, older patients
had significantly more tissue neutrophils and bacterial
culture-positive purulence than younger patients, and age
was positively correlated with mucus levels of pro-
inflammatory cytokines such as IL-1ß, IL-6, IL-8, and
TNF-α [39••]. Collectively, the findings are inconsistent
so far, and it is unclear whether age can have major in-
fluence on the immunological phenotypes of CRSwNP.
However, the lack of consistency among cross-sectional
studies suggests possible complex age relationships,
which is likely to be non-linear, and indicates the need
for longitudinal investigations to elucidate aging-related
changes in inflammatory phenotypes of CRSwNP.
Age-Related Clinical Characteristics
of CRSwNP
Using the KNHANES 2010–2012 database, we examined
age-related differences in the pattern of cardinal symptoms
and the presence of nasal polyps among CRS patients from
the general population. Interestingly, contrasting patterns were
observed between age groups—older patients reported more
loss of smell, but less rhinorrhea or nasal obstruction, than did
younger patients (Fig. 1b; unpublished data). These findings
suggest that the clinical presentation of CRS in older patients
is likely to be less typical than in younger patients. Aging-
related anatomical and physiological changes—such as nasal
mucosal atrophy, decreased nasal vasculature, or decreased
nasal mucus secretion [18]—may underlie the age-related dif-
ferences in nasal symptom profiles.
Studies based on data from specialist clinics have reported
age-related differences in the clinical characteristics of
CRSwNP, including the post-operative prognosis. Brescia
et al. compared the clinical characteristics and post-operative
clinical courses of 43 older patients and 71 young patients with
CRSwNP after ESS [37, 40]. At baseline, there was no signif-
icant difference in the prevalence of asthma, aspirin-
exacerbated respiratory diseases, and blood or nasal polyp tis-
sue eosinophilia between the two age groups [40]. However,
the recurrence rate of nasal polyps (defined as endoscopic evi-
dence of at least grade I polyposis during a follow-up of ap-
proximately 2 years) was lower in older patients than in youn-
ger patients (11.6% vs. 28.2%; p = 0.05) [37]. Similar findings
were observed in patient studies from Korea, where non-
eosinophilic nasal polyposis is a predominant pathologic
subtype [38•]. Kim and colleagues found that older patients
with CRSwNP had significantly lower pre-operative Lund-
Mackay CT scores and better post-operative endoscopic scores
at 12months than did younger patients [38•]. In another Korean
study of 60 CRSwNP patients undergoing ESS, post-operative
endoscopic scores at 6 months were better in older patients than
in younger ones [41]. A small study of 20 patients undergoing
ESS for CRSwNP suggested that a lower cellular proliferative
ability, measured and evaluated based on proliferating cell nu-
clear antigen and Ki67 reactivity in tissues, might be related to
better surgical outcomes in older patients [42].
Late-Onset Asthma in Patients with CRSwNP
Asthma is a major comorbid condition in patients with
CRSwNP (up to 60%) [32•, 43]. This is particularly rele-
vant clinically because in such cases, asthma frequently
shows late onset and is difficult to treat [1]. In the
KNHANES 2010–2012 analysis, unlike in individuals
without CRS or with CRSsNP, age at asthma onset was
typically above 40 years in patients with CRSwNP [7•]. It
is still unknown whether CRSwNP predisposes to asthma or
vice versa. Meanwhile, CRSwNP comorbidity is closely re-
lated to asthma severity in older patients with asthma [44].
Despite consistently reported associations between CRSwNP
and asthma in large adult population studies [6, 7•, 11, 13, 14],
the mechanisms underlying these associations are not fully un-
derstood. However, interestingly, CRSwNP and asthma fre-
quently present with type 2 inflammatory signatures when they
are comorbid. In a cluster analysis of CRS patients based on
immunological biomarkers, 10 clusters with distinct cytokine
patterns were identified, correlating with clinical phenotypes in
terms of nasal polyps and asthma comorbidity [32•]. Notably, the
high IL-5 clusters showed increased local levels of total IgE and
staphylococcal enterotoxin-specific IgE (SE-IgE) in nasal tissues
and also a higher frequency of nasal polyps and asthma [32•].
Asthma comorbidity is more frequent in refractory CRSwNP
patients with type 2 high inflammatory signature than in those
with non-refractory or non-eosinophilic CRSwNP [45].
Meanwhile, in a cohort study of older patients with late-onset
asthma, CRSwNP was found to be closely related to severe
eosinophilic asthma and elevated SE-IgE serum levels [46•].
As patients with CRSwNP or late-onset asthma are frequent-
ly non-atopic, causative factors other than inhalant allergen IgE
sensitization are postulated to drive the type 2 inflammatory
process. Unlike inhalant IgE sensitization, the SE-IgE sensiti-
zation rate may increase with aging or remain high in older
adults and is positively associated with asthma prevalence in
general populations [47•, 48•]. In a recent nested case-control
study from the 20-year Epidemiological study on the Genetics
and Environment of Asthma-EGEA cohort, SE-IgE sensitiza-
tion was also significantly associated with asthma severity
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(adjusted OR 2.69; 95% CI 1.18–6.15) and asthma exacerba-
tions (adjusted OR 4.59; 95% CI 1.40–15.07) 10–20 years
later [49]. As S. aureus is a frequent colonizer in the nasal mu-
cosa and its colonization is positively associated with asthma in
adults [27], the common associations of SE-IgE, an immunologic
marker for host interactions, suggest that the bacterial exposure is
one of important factor linking between CRSwNP and asthma.
Meanwhile, as nasal colonization by S. aureus is only modestly
associated with asthma [27, 50], certain host interactions would
be key to developing SE-IgE sensitization and allergic inflam-
mation. As SE-IgE sensitization is more common in smokers
[48•], environmental irritant exposure, such as cigarette smoking,
is postulated to have adjuvant effects.
Staphylococcus aureus can reside and proliferate within
host cells in nasal polyp tissues, including epithelial cells
and mast cells [51–53]. Importantly, S. aureus produces bac-
terial proteins that can initiate or exacerbate type 2 inflamma-
tion of the airways [54]. Staphylococcal serine protease–like
proteins (Spls) are recently identified bacterial proteins that
can induce type 2 inflammation in an IL-33-dependent man-
ner [55•, 56••]. Asthma patients have significantly higher levels
of IgE relative to Spls than do controls without asthma.
Moreover, in mice, repeated intratracheal administration of
SplD without an adjuvant leads to eosinophilic lung inflamma-
tion and SplD-specific IgE sensitization [56••], indicating poten-
tial key roles of Spls in the pathogeness of S. aureus-related
airway diseases such as CRSwNP and asthma of late-onset.
Other Comorbidities in Patients with CRSwNP
Otitis media is another frequent comorbid condition in patients
with CRS [57]. In a cross-sectional study of 80 patients with
CRSwNP, chronic otitis media (COM) with effusion was found
in 25% of the patients [58]. In the KNHANES 2009–2012
database analyses by Hong and colleagues, where COM was
defined by otologic endoscopic findings of tympanic membrane
perforation or cholesteatoma, the overall prevalence of COM
was 3.6 ± 0.2% (95% CI 3.3–3.9%) and increased with age
[59•]. COM was significantly associated with CRSwNP (vs. no
CRS as the reference; adjusted OR 1.920; 95% CI 1.080–3.410)
but not with CRSsNP (adjusted OR 1.504; 95% CI 0.608–
3.718). Notably, the associations between CRSwNP and COM
were significant in older adults (> 50 years) but not in younger
adults (19–49 years) [59•].
Head and neck cancers are very rare, but their relative risks
reportedly increase in older patients with CRS or nasal polyps. In
recent analyses of the SEER-Medicare database containing
483,546 older adults (≥ 60 years) from the USA, CRSwas found
to be associatedwith the nasal cavity and paranasal sinus (NCPS)
and nasopharyngeal cancers [60, 61]. In a nationwide
population-based retrospective longitudinal cohort study of
453,892 patients with nasal polyps and 4,583,938 matched com-
parators from Korea (mean duration of follow-up 6.2 years), the
incidence rate ratios of nasal polyps were 7.00 (95% CI 5.28–
9.25) for NCPS cancer and 1.78 (95% CI 1.28–2.42) for naso-
pharyngeal cancer. However, the increased risks were only evi-
dent in older patients (≥ 50 years) [62•]. Given the regional and
pathological heterogeneity of nasal polyps, further validation
studies are warranted to confirm their relationship with these
cancers. However, these findings suggest that further clinical
attention might need to be paid to CRSwNP occurring at an
advanced age.
Conclusion
CRSwNP is a common condition that significantly affects the
patient’s life. It may cause severe nasal symptoms and fre-
quently co-exists with severe asthma. Notably, CRSwNP is a
Fig. 2 Summary of age-related changes in epidemiology, clinical presentations, and pathophysiology of chronic rhinosinusitis with nasal polyps
(CRSwNP)
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mostly late-onset disease with different inflammatory
endotypes. The pathophysiology is likely to be more complex
in older adults, as it would include age-related changes in
biologic functions (Fig. 2). Unlike younger patients, older pa-
tients with CRSwNP may present with less typical symptoms,
with less frequent nasal obstruction or discharge. However,
there is still a paucity of evidence on the effect of aging on
phenotypes and endotypes of CRSwNP. Available evidence
suggests that the effects are likely to be complex, as reflected
by the discrepant findings between published cross-sectional
studies. Thus, longitudinal investigations are warranted to un-
derstand the effects of aging. Meanwhile, late-onset asthma
is a major comorbid condition in patients with CRSwNP
and is frequently difficult to treat. Such patients may pres-
ent with type 2 inflammatory signatures, and chronic repeated
exposure to S. aureus and subsequent host immune responses
may underlie these relationships. There are additional comor-
bidity associations in older patients with CRSwNP, including
those with COM and malignancy. These findings collectively
indicate the need for more comprehensive research and a clin-
ical approach to CRSwNP in older adults.
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